REPLAY & MEETING SLIDES

Home > Replay

Welcome Remarks from IABS & Chairs

Viral Safety of Biologic

Arifa KHAN
USFDA, FDA-CBER, U.S.A. – Co-Chair

Cases of contamination with adventitious viral agents in Biological Products

Carine LOGVINOFF
Sanofi, France

What is NGS?

Siemon NG
Notch Therapeutics, Canada

Panel Discussion

Welcome Remarks from IABS & Chairs

Advanced Virus Detection Technologies Working Group (AVDTWG) overview

Siemon NG
Notch Therapeutics, Canada

Noémie DENEYER
GlaxoSmithKline (GSK) Vaccines, Belgium

Overview of ICHQ5A (R2)

Johannes BLÜMEL
PEI, Germany

FDA Perspectives

Arifa KHAN
USFDA, FDA-CBER, U.S.A. – Co-Chair

WHO Perspectives

Ivana KNEZEVIC
WHO, Switzerland

Panel Discussion: Regulatory Expectations and Industry Perspectiveserspectives